Azur Pharma Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 751

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

  • Investments
  • 3

Azur Pharma General Information

Description

Developer of biopharmaceutical products intended to focus on improving patients' lives by identifying, developing, and commercializing meaningful products that address unmet medical needs. The company's products are used for the treatment of cataplexy and excessive daytime sleepiness, acute lymphoblastic leukemia and severe hepatic veno-occlusive disease.

Contact Information

Website
azurpharma.com
Formerly Known As
Azur Pharma Ltd
Ownership Status
Acquired/Merged
Financing Status
Corporation
Corporate Office
  • Waterloo Exchange
  • Waterloo Road
  • Dublin 4
  • Ireland
+353 (01)
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Waterloo Exchange
  • Waterloo Road
  • Dublin 4
  • Ireland
+353 (01)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Azur Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Azur Pharma‘s full profile, request access.

Request a free trial

Azur Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biopharmaceutical products intended to focus on improving patients' lives by identifying, developing, and c
Pharmaceuticals
Dublin, Ireland
751 As of 2015

Boston, MA
 

Stamford, CT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Azur Pharma Competitors (9)

One of Azur Pharma’s 9 competitors is Ironwood Pharmaceuticals, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ironwood Pharmaceuticals Formerly VC-backed Boston, MA
Purdue Pharma Corporation Stamford, CT
Intellipharmaceutics International Corporation Toronto, Canada
Gilead Sciences Formerly VC-backed Foster City, CA
Elite Pharmaceuticals Corporation Northvale, NJ
You’re viewing 5 of 9 competitors. Get the full list »

Azur Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Azur Pharma Investments & Acquisitions (3)

Azur Pharma’s most recent deal was a Merger/Acquisition with Alizé Pharma II for . The deal was made on 11-Mar-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Alizé Pharma II 11-Mar-2016 Merger/Acquisition Pharmaceuticals
Pharmelle 26-Feb-2007 Merger/Acquisition Drug Discovery
UCB Pharma (Gastrocrom rights) 18-Jan-2006 Corporate Asset Purchase Buildings and Property
To view Azur Pharma’s complete investments and acquisitions history, request access »

Azur Pharma FAQs

  • When was Azur Pharma founded?

    Azur Pharma was founded in 2006.

  • Where is Azur Pharma headquartered?

    Azur Pharma is headquartered in Dublin, Ireland.

  • What is the size of Azur Pharma?

    Azur Pharma has 751 total employees.

  • What industry is Azur Pharma in?

    Azur Pharma’s primary industry is Pharmaceuticals.

  • Is Azur Pharma a private or public company?

    Azur Pharma is a Private company.

  • What is the current valuation of Azur Pharma?

    The current valuation of Azur Pharma is .

  • What is Azur Pharma’s current revenue?

    The current revenue for Azur Pharma is .

  • Who are Azur Pharma’s competitors?

    Ironwood Pharmaceuticals, Purdue Pharma, Intellipharmaceutics International, Gilead Sciences, and Elite Pharmaceuticals are some of the 9 competitors of Azur Pharma.

  • When was Azur Pharma acquired?

    Azur Pharma was acquired on 18-Jan-2012.

  • Who acquired Azur Pharma?

    Azur Pharma was acquired by Jazz Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »